Echosens Webinar - Pronostic value of FibroScan and FibroMeter in Chronic liver diseases

➡️ CHECK OUT OUR MOST RECENT WEBINARS IN REPLAY ➡️ bit.ly/echosen...
Pronostic value of FibroScan and FibroMeter in Chronic liver disease
Speakers: Pr.Wah Kheong CHAN & Pr. Sanjiv MAHADEVA
Contact: [e-mail]
Program:
1. Prognostic value of LSM measured by FibroScan
2. Prognostic value of blood markers and focus on FibroMeter
3. Take home messages
4. Clinical cases (around 3 clinical cases illustrating the topics)
5. Q & A session
Legal Mentions:
ECHOSENS_WEBINAR_REPLAY2016- Revision date 11/9/2016 - FibroScan® is a medical device manufactured by Echosens. FibroScan is a CE marked Medical Device within the scope of the Medical Devices Directive. FibroScan® is indicated for the non invasive measurement of liver stiffness (E) and controlled attenuation parameter (CAP) in humans. It is expressly recommended to carefully read the guidance within the users' guide and the labeling of the device. FibroScan® examinations must only be performed at the request of qualified physician and by operators certified by the manufacturer or its accredited local representative. The values obtained with FibroScan® must be interpreted by a physician experienced in dealing with liver disease, taking into account the complete medical record of the patient.
DISCLAIMER : Our products are subject to regulatory requirements that vary from country to country and therefore may not be available for sale or distribution in all markets. This video is not intended for US audience : www.echosens.us/ .